Corona Remedies Share Price: Corona Remedies debuted on Dalal Street with a significant 38.42% premium, opening at Rs 1,470 on NSE and Rs 1...

Corona Remedies and Wakefit Innovations are set to list amid divergent grey market signals. Corona Remedies commands strong listing expecta...

Corona Remedies’ IPO opened with decent subscription demand, led by strong retail demand and a robust Rs 290 grey-market premium. The Rs 65...

Corona Remedies is set to raise ₹655.4 crore via an offer for sale. The company focuses on specialist doctors, driving faster revenue growt...

Ahmedabad-based pharmaceutical company CORONA Remedies has acquired the muscle relaxant brand Myoril from Sanofi India for Rs234 crore. The...

According to her, most M&As, particularly those with an international component, seek to protect some of it. "India is a growing and unders...

Social media emerged as a lifeline for many during the second wave of the pandemic.

Creador III acquired a minority stake in Corona Remedies in July 2016, for Rs 118 crore. With this exit, Creador III has realised 15 per ce...

Hopeful for an economic revival with the falling cases of coronavirus in the country and that people are getting vaccinated, he said huge o...

In FY20, its revenue growth was muted followed by a mere 1% growth in the first half of FY21. However, the trend may reverse since analysts...

Nomura India Business Resumption Index (NIBRI) rose to yet another post-lockdown high of 85.8 for the week ended November 8, from 84.7 post...

Asia's third-largest economy is healing after shrinking a record 23.9% in the April-June quarter. The Nikkei Manufacturing Purchasing Manag...

There was a "very firm lockdown" imposed beginning March 25 as the government put lives before livelihood. The lockdown also gave time to d...

The popularity of the two standardised policies has been growing substantially, according to Alamelu. After an initial spurt in the number ...

Corona Kavach, which was launched on July 10 and is being offered by both general and health insurers, is a standard health insurance polic...

Cydista Ltd, an affiliate of Creador III L.P., has committed Rs 118 crore ($17.6 million) for a minority stake in Corona Remedies Private L...

Belgium life science company, Kitozyme entered into in-licensing agreement with Corona Remedies for fat binder anti-obesity drug.